ArticleRevista panamericana de salud publica = Pan American journal of public health2025
[Implementation of hypertension and diabetes care pathways in two regions of the Brazilian NortheastImplementación de las líneas de cuidado para la hipertensión y la diabetes en dos regiones del nordeste brasileño].
Article in Revista panamericana de salud publica = Pan American journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative Monitoring of Hypertension Care Using Routinely Collected Clinical Data in Mexico's Emerging Federalised Public Health Care Provider.Health services insights · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the implementation of care pathways for systemic arterial hypertension (SAH) and type 2 diabetes (T2DM) at the primary health care level in two regions of Northeastern Brazil. Methods: A descriptive, cross-sectional, before-and-after analysis was conducted, involving the identification of barriers to implementation, situational diagnosis, development of an implementation plan, health team training, and implementation assessment through a self-administered questionnaire. The following clinical indicators were evaluated: proportion of individuals with stratified cardiovascular risk among the total number of patients; proportion of individuals with SAH or T2DM who achieved blood pressure and glycemic control; and percentage of patients diagnosed with SAH or T2DM. Results: Implementation began in January 2023 in the 1st Health Region of Mata Atlântica (1RSPB, state of Paraíba) and in June 2023 in the 7th Metropolitan Health Region (7RSRN, state of Rio Grande do Norte). The final assessment occurred in December 2023. In the 1RSPB, increases were noted in the percentages of cardiovascular risk stratification (0 to 36%, P < 0.001), blood pressure control (33.4% to 62.6%, P < 0.001), and glycemic control (26.7% to 77.9%, P < 0.001). In the 7RSRN, cardiovascular risk stratification increased from 0 to 17.4%. Changes in the percentages of patients with controlled SAH (47.9% to 48.4%, P = 0.72) and T2DM (59.2% to 57.3%, P = 0.41) were not statistically significant. Conclusion: The implementation of HTN and T2DM care pathways was feasible, with greater improvements observed in the healthcare network with lower baseline control levels and longer implementation duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.